FATTY-ACID METABOLISM IN NORMOTENSIVE AND HYPERTENSIVE RATS .2. DISTRIBUTION AND OXIDATION OF DIETARY [1-14C]-18-2N-6 AND [1-14C]-18-3N-3

被引:4
|
作者
MILLS, DE [1 ]
WARD, RP [1 ]
MAH, M [1 ]
HUANG, YS [1 ]
机构
[1] EFAMOL RES INST,KENTVILLE,NS,CANADA
基金
加拿大自然科学与工程研究理事会;
关键词
essential fatty acids; hypertension; lipids; metabolism; oxidation; SHR;
D O I
10.1016/S0271-5317(05)80513-5
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
To determine whether genetically normotensive and hypertensive rats differentially oxidize and incorporate dietary n-3 and n-6 fatty acids, male Wistar Kyoto (WKY) and spontaneously hypertensive (SHR) rats (n=36/strain) were placed on fat-free semi-purified diet for 8 weeks following weaning. After a 12 hr fast they received an i.g. bolus of [1-14C]-18:2n-6 or [1-14C]-18:3n-3 (28μg) in 0.4 ml olive oil. Animals were killed at 2, 8, and 24 hr post administration (n=6/strain) and tissues were collected for assessment of 14C incorporation. Also, the 24 hr group was placed in metabolic boxes and expired 14CO2 was measured at 2, 4, 6, 8, and 24 hr post administration in order to approximate whole body oxidation. In WKY and SHR, oxidation of 18:3 exceeded that of 18:2. In SHR, 18:2 and 18:3 oxidation was greater than that of WKY, and the ratio of oxidized 18:3 vs. 18:2 was greater than in the WKY. In addition, in adipose tissue, incorporation of [1-14C]-18:3-derived 14C, but not of [1-14C]-18:2-derived 14C, was reduced in the SHR vs. WKY. Incorporation of 14C from [1-14C]-18:2 was increased in liver, lung, skeletal muscle, heart, and brain of SHR vs. WKY and that from [1-14C]-18:3 was increased in kidney, heart, and brain of SHR vs. WKY. These data suggest that the hypertensive SHR exhibits differences in its utilization of n-3 and n-6 fatty acids vs. the normotensive WKY. These differences suggest that the SHR may be less responsive to dietary n-3 fatty acid manipulation than the WKY, and that the dietary requirements for n-3 fatty acids may be higher in the SHR than the WKY. © 1990 Pergamon Press plc. All rights reserved.
引用
收藏
页码:675 / 681
页数:7
相关论文
共 27 条
  • [21] STUDY ON THE METABOLIC-FATE OF CATENA-(S)-(MU-(N-ALPHA-(3-AMINOPROPIONYL)HISTIDINATO(2-)-N1,N2,O-N-TAU)-ZINC) .2. ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION AFTER REPEATED ADMINISTRATION TO RATS
    TOYAMA, S
    FURUTA, S
    MIWA, M
    SUZUKI, M
    SANO, H
    MATSUDA, K
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1991, 41-2 (09): : 976 - 983
  • [22] Comparative pharmacokinetics of [C-14]metosulam (N-[2,6-dichloro-3-methylphenyl]-5,7-dimethoxy-1,2,4-triazolo-[1,5 alpha]-pyrimidine-2-sulfonamide) in rats, mice and dogs
    Timchalk, C
    Dryzga, MD
    Johnson, KA
    Eddy, SL
    Freshour, NL
    Kropscott, BE
    Nolan, RJ
    JOURNAL OF APPLIED TOXICOLOGY, 1997, 17 (01) : 9 - 21
  • [23] Metabolism and disposition of 2-ethylhexyl-p-methoxycinnamate following oral gavage and dermal exposure in Harlan Sprague Dawley rats and B6C3F1/N mice and in hepatocytes in vitro
    Fennell, Timothy R.
    Mathews, James M.
    Snyder, Rodney W.
    Hong, Yan
    Watson, Scott L.
    Black, Sherry R.
    McIntyre, Barry S.
    Waidyanatha, Suramya
    XENOBIOTICA, 2018, 48 (11) : 1142 - 1156
  • [24] Toxicokinetics of bis(2-chloroethoxy)methane following intravenous administration and dermal application in male and female F344/N rats and B6C3F1 mice
    Waidyanatha, S.
    Johnson, J. D.
    Hong, S. P.
    Godfrey-Robinson, V. D.
    Graves, S. W.
    Cristy, T.
    Dunnick, J. K.
    Smith, C. S.
    TOXICOLOGY LETTERS, 2011, 205 (02) : 215 - 226
  • [25] Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography
    Roivainen, Anne
    Nayengren, Kjell
    Hirvonen, Jussi
    Oikonen, Vesa
    Virsu, Pauliina
    Tolvanen, Tuula
    Rinne, Juha O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (04) : 671 - 682
  • [26] Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography
    Anne Roivainen
    Kjell Någren
    Jussi Hirvonen
    Vesa Oikonen
    Pauliina Virsu
    Tuula Tolvanen
    Juha O. Rinne
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36
  • [27] Investigation of the unique metabolic fate of ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242) in rats and dogs using two types of 14C-labeled compounds having different labeled positions
    Jinno, Fumihiro
    Kakehi, Masaaki
    Takeuchi, Toshiyuki
    Tagawa, Yoshihiko
    Kondo, Takahiro
    Asahi, Satoru
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2011, 61 (08): : 458 - 471